Combination therapy of urogenital embryonal rhabdomyosarcoma in children

Abstract

Twenty-seven children with embryonal rhabdomyosarcoma of the urogenital tract were treated between 1960-1971. A review of their courses reveals that early stage of the disease at the time of diagnosis and multidisciplinary therapy —surgery, radiotherapy, and multiple drug therapy—offer the best chance for prolonged survival and cure. Seventeen (63%) of the 27 children are living and have been free of the tumor for 18 months-10 years.